HB-110

· Genexine, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HB-110, covering 2013-06-20 to 2013-06-20. Get the full timeline:

Most recent: Clinical Trial Update: Tolerability, Immunogenicity and Efficacy of HB-110 Administered by Electroporation in Chronic Hepatitis B Patients [Phase 1]

See pricing